
At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).

At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).

The patient had hemophilia A, but reported no trauma preceding the hematoma.

Elizabeth Johnson, LPN, PACS, BPCA, CEO of MedicoCX, co-CEO of Healthcare Advocate Summit, and an Asembia 2023 presenter, discusses why more empathetic approaches that take into account the full range of the patient experience are needed to improve patient-focused health care.

Despite similar health care utilization, White patients were much more likely to receive and fill prescriptions for medications to treat opioid use disorder (OUD) compared with Black or Hispanic patients in the months following a high-risk OUD event such as an overdose, a new study has found.

The results indicate that the program could play a role in discouraging use of biosimilars in the United States.

The training did not, however, affect postoperative limb skeletal muscle weakness or exercise capacity.

Researchers compared chimeric antigen receptor T-cell therapies axicabtagene ciloleucel (axi-cel) and tisagenlecleucel.

Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.

Panelists from Optum Life Sciences, OptumRx, and Takeda discussed the importance of collaboration in creating successful value-based agreements (VBAs) at Asembia 2023.

The American Journal of Managed Care® interviewed 2 presenters at Asembia 2023, gaining insight on how the specialty pharmacy pipeline is growing and how health systems and payers can affect the accessibility and affordability of new specialty therapies.

The FDAs newest blood donation guidance may expand donation eligibility; Pfizer CEO anticipates lawsuits to stop US drug price plan; drug shortages have worsened and may increase even with the end of the COVID-19 public health emergency.

The Dario Diabetes Solution app was developed to help better manage type 2 diabetes.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Jessica Robinson-Papp, MD, MS, professor of neurology at the Icahn School of Medicine at Mount Sinai, talks about the strides made in antiretroviral therapy for HIV and how these improvements lead to better patient outcomes.

Patients who have extrinsic (EAD) or intrinsic atopic dermatitis (IAD) serve to benefit equally from dupilumab, even when considering immunoglobulin E levels, which are elevated in EAD but remain normal in IAD.

Mailing at-home human papillomavirus (HPV) self-collection tests and providing booking assistance for in-clinic screening visits nearly doubled the rate of cervical cancer screenings among underscreened women from low-income backgrounds vs offering scheduling assistance alone.

Medication adherence for patients with asthma can be improved through patient empowerment by way of effective dialogue and appropriate education, according to a recent review.

Many adolescents and young adults (AYAs) with advanced heart disease prefer to be involved in decisions that have an impact on their medical care, but new survey results show there is a great need for educational communication efforts that involve their caregivers and clinicians.

The end of the national Public Health Emergency (PHE) also concludes some public support programs; FDA advisers unanimously recommended that the agency should approve OTC birth control pills; insulin manufacturers and pharmacy benefit managers testified on Capitol Hill Wednesday over the cost of the drug.

Knowledge is limited on the potential exclusion from pay-for-performance (P4P) programs of patients living with diabetes who have with individual or neighborhood social risks.

“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.

Just 29% of patients listed a treatment-response goal among their top personal goals.

Speakers at the 2023 Asembia Specialty Pharmacy Summit outlined how artificial intelligence (AI) tools for pharmaceuticals, such as parcel tracking, could reduce operational costs for specialty pharmacies and mitigate drug delivery issues for patients.

Findings show these drugs were linked with a lower risk of progression to inflammatory arthritis compared with tumor necrosis factor inhibitors, although more research is needed to confirm the finding.

This form of reinforcement learning was also shown to correct for control scenarios like irregular meal timing and compression errors.

Biotech company EQRx discards low-cost drug plan, cuts its therapy programs to 1, and slashes staff in “reset”; health care systems’ preparation for new Alzheimer disease drug takes location and resources into consideration; the Drug Enforcement Administration (DEA) will extend telemedicine prescribing for certain controlled medications through at least November 11.

Treatment with dupilumab demonstrated improvements in histological markers, symptoms, and endoscopic markers of eosinophilic esophagitis (EoE) regardless of previous history of esophageal dilation.

No benefit was found in low-risk patients who underwent pelvic lymph node dissection (PLND).

The behavioral economic biases of 43 African American young adults aged 18 to 24 were evaluated on 4 fronts: present bias, information salience, overoptimism, and loss aversion.

The results of a new focus group offer insights on how and when people with rare diseases are willing to share their personal health information.